Paper外送
3免費公開
Sharing of latest medical information and articles
An increased risk of NODM was observed in patients achieved lower LDL-C levels following high-intensity rosuvastatin therapy.
An increased risk of NODM was observed in patients achieved lower LDL-C levels following high-intensity rosuvastatin therapy.
An increased risk of NODM was observed in patients achieved lower LDL-C levels following high-intensity rosuvastatin therapy.
An increased risk of NODM was observed in patients achieved lower LDL-C levels following high-intensity rosuvastatin therapy.